Your browser doesn't support javascript.
loading
Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia.
Bewersdorf, Jan Philipp; Patel, Kishan K; Goshua, George; Shallis, Rory M; Podoltsev, Nikolai A; Huntington, Scott F; Zeidan, Amer M.
Afiliación
  • Bewersdorf JP; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, and.
  • Patel KK; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT.
  • Goshua G; Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and.
  • Shallis RM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, and.
  • Podoltsev NA; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT.
  • Huntington SF; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, and.
  • Zeidan AM; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA.
Blood ; 139(11): 1766-1770, 2022 03 17.
Article en En | MEDLINE | ID: mdl-35298594
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Health_economic_evaluation Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Health_economic_evaluation Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article